Pralsetinib + Mao Inhibitors Interaction
Majorinteraction on record
Description
Concomitant use increases pralsetinib exposure, which may increase the risk of adverse reactions. Avoid coadministration; if unavoidable, reduce GAVRETO dose.
Mechanism
CYP3A inhibition increases pralsetinib exposure
Source: NLP:pralsetinib